IL23565A - Administration of ovulation-controlling medicaments to domestic animals - Google Patents
Administration of ovulation-controlling medicaments to domestic animalsInfo
- Publication number
- IL23565A IL23565A IL2356565A IL2356565A IL23565A IL 23565 A IL23565 A IL 23565A IL 2356565 A IL2356565 A IL 2356565A IL 2356565 A IL2356565 A IL 2356565A IL 23565 A IL23565 A IL 23565A
- Authority
- IL
- Israel
- Prior art keywords
- sponge
- impregnated
- dione
- ene
- ovulation
- Prior art date
Links
- 241001465754 Metazoa Species 0.000 title claims description 55
- 239000003814 drug Substances 0.000 title description 4
- 150000001875 compounds Chemical class 0.000 claims description 45
- 230000016087 ovulation Effects 0.000 claims description 40
- 230000001072 progestational effect Effects 0.000 claims description 40
- 238000000034 method Methods 0.000 claims description 24
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 claims description 22
- 150000003431 steroids Chemical class 0.000 claims description 22
- 210000001215 vagina Anatomy 0.000 claims description 15
- 229960003387 progesterone Drugs 0.000 claims description 11
- 239000000186 progesterone Substances 0.000 claims description 11
- 241000283690 Bos taurus Species 0.000 claims description 10
- 230000035558 fertility Effects 0.000 claims description 10
- 230000006698 induction Effects 0.000 claims description 9
- 238000003780 insertion Methods 0.000 claims description 8
- 230000037431 insertion Effects 0.000 claims description 8
- 230000009027 insemination Effects 0.000 claims description 7
- -1 carbonyl radical Chemical class 0.000 claims description 6
- 229910052739 hydrogen Inorganic materials 0.000 claims description 3
- 239000001257 hydrogen Substances 0.000 claims description 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 3
- WCYWZMWISLQXQU-UHFFFAOYSA-N methyl Chemical compound [CH3] WCYWZMWISLQXQU-UHFFFAOYSA-N 0.000 claims description 2
- 125000004432 carbon atom Chemical group C* 0.000 claims 1
- 125000001153 fluoro group Chemical group F* 0.000 claims 1
- 230000012173 estrus Effects 0.000 description 15
- 239000000583 progesterone congener Substances 0.000 description 13
- 238000009395 breeding Methods 0.000 description 11
- 230000001488 breeding effect Effects 0.000 description 11
- 230000001276 controlling effect Effects 0.000 description 10
- 102000006771 Gonadotropins Human genes 0.000 description 5
- 108010086677 Gonadotropins Proteins 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 239000002622 gonadotropin Substances 0.000 description 5
- 238000002347 injection Methods 0.000 description 5
- 239000007924 injection Substances 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 241000283707 Capra Species 0.000 description 3
- 125000000217 alkyl group Chemical group 0.000 description 3
- 230000003542 behavioural effect Effects 0.000 description 3
- 125000004122 cyclic group Chemical group 0.000 description 3
- 239000000262 estrogen Substances 0.000 description 3
- 229940011871 estrogen Drugs 0.000 description 3
- 238000005470 impregnation Methods 0.000 description 3
- 230000006651 lactation Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000004033 plastic Substances 0.000 description 3
- 229920003023 plastic Polymers 0.000 description 3
- 229920002635 polyurethane Polymers 0.000 description 3
- 239000004814 polyurethane Substances 0.000 description 3
- UYIFTLBWAOGQBI-BZDYCCQFSA-N Benzhormovarine Chemical compound C([C@@H]1[C@@H](C2=CC=3)CC[C@]4([C@H]1CC[C@@H]4O)C)CC2=CC=3OC(=O)C1=CC=CC=C1 UYIFTLBWAOGQBI-BZDYCCQFSA-N 0.000 description 2
- 239000004677 Nylon Substances 0.000 description 2
- 241001494479 Pecora Species 0.000 description 2
- 239000004721 Polyphenylene oxide Substances 0.000 description 2
- 125000002015 acyclic group Chemical group 0.000 description 2
- 239000003098 androgen Substances 0.000 description 2
- 229940030486 androgens Drugs 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 229950002007 estradiol benzoate Drugs 0.000 description 2
- 229940094892 gonadotropins Drugs 0.000 description 2
- 229920001778 nylon Polymers 0.000 description 2
- 229920000728 polyester Polymers 0.000 description 2
- 229920000570 polyether Polymers 0.000 description 2
- 230000003389 potentiating effect Effects 0.000 description 2
- 230000035935 pregnancy Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 238000007920 subcutaneous administration Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 229920000742 Cotton Polymers 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 235000019687 Lamb Nutrition 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000010339 dilation Effects 0.000 description 1
- 230000001158 estrous effect Effects 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 230000004720 fertilization Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000004459 forage Substances 0.000 description 1
- 244000144993 groups of animals Species 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229920003052 natural elastomer Polymers 0.000 description 1
- 229920001194 natural rubber Polymers 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920000098 polyolefin Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000003254 radicals Chemical group 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000001932 seasonal effect Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 238000004513 sizing Methods 0.000 description 1
- 230000003637 steroidlike Effects 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 229920003051 synthetic elastomer Polymers 0.000 description 1
- 239000005061 synthetic rubber Substances 0.000 description 1
- 150000003673 urethanes Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61D—VETERINARY INSTRUMENTS, IMPLEMENTS, TOOLS, OR METHODS
- A61D7/00—Devices or methods for introducing solid, liquid, or gaseous remedies or other materials into or onto the bodies of animals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
- G01N33/76—Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Public Health (AREA)
- Urology & Nephrology (AREA)
- Medicinal Chemistry (AREA)
- Endocrinology (AREA)
- Physics & Mathematics (AREA)
- Epidemiology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Reproductive Health (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Materials For Medical Uses (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU44703/64A AU404759B2 (en) | 1965-05-03 | A sponge impregnated with progestational coompound and the use thereof for controlling ovulation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL23565A true IL23565A (en) | 1969-02-27 |
Family
ID=3731915
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL2356565A IL23565A (en) | 1964-05-20 | 1965-05-19 | Administration of ovulation-controlling medicaments to domestic animals |
Country Status (5)
| Country | Link |
|---|---|
| BE (1) | BE664181A (enrdf_load_stackoverflow) |
| BR (1) | BR6569750D0 (enrdf_load_stackoverflow) |
| FR (1) | FR1482828A (enrdf_load_stackoverflow) |
| GB (1) | GB1067505A (enrdf_load_stackoverflow) |
| IL (1) | IL23565A (enrdf_load_stackoverflow) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1204117A (en) * | 1966-09-08 | 1970-09-03 | Syntex Corp | Devices and methods for administering pharmaceutical preparations |
| FR2562797A1 (fr) * | 1984-04-17 | 1985-10-18 | Synkron Corp | Implant susceptible de liberer un principe actif |
| AU2002358400A1 (en) * | 2001-11-28 | 2003-06-10 | Wolfgang Knogler | Device for incorporating substances which contain a sea sponge as a support |
| AT6723U3 (de) * | 2003-10-06 | 2004-05-25 | Knogler Wolfgang | Einrichtung zum einbringen von stoffen |
-
1965
- 1965-05-04 GB GB1879265A patent/GB1067505A/en not_active Expired
- 1965-05-19 IL IL2356565A patent/IL23565A/en unknown
- 1965-05-19 BR BR16975065A patent/BR6569750D0/pt unknown
- 1965-05-19 BE BE664181D patent/BE664181A/xx unknown
- 1965-09-04 FR FR30475A patent/FR1482828A/fr not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| GB1067505A (en) | 1967-05-03 |
| BR6569750D0 (pt) | 1973-08-16 |
| BE664181A (enrdf_load_stackoverflow) | 1965-11-19 |
| FR1482828A (fr) | 1967-06-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US3916898A (en) | Administration of medicaments and the like | |
| Loy et al. | Effects of exogenous progestogens on reproductive phenomena in mares | |
| Deanesly et al. | Factors influencing the effectiveness of administered hormones | |
| Robinson | Control of the ovarian cycle in the sheep | |
| Ulberg et al. | Use of progesterone and estrogen in the control of reproductive activities in beef cattle | |
| McGinty et al. | Effect of local application of progesterone on the rabbit uterus | |
| Roche | Synchronization of oestrus in heifers with implants of progesterone | |
| Melampy et al. | The effect of progesterone on the estrous response of estrogen-conditioned ovariectomized cows | |
| Heersche Jr et al. | Synchronization of estrus in beef heifers with a norgestomet implant and prostaglandin F2α | |
| US3528419A (en) | Devices and methods for administering pharmaceutical preparations | |
| Munro et al. | Circa-annual rhythms of prolactin secretion in ewes and the effect of pinealectomy | |
| Carrick et al. | The synchronization of oestrus in cattle with progestagen-impregnated intravaginal sponges | |
| US3565991A (en) | Methods for use and compositions of 17alpha-ethyl-19-nortestosterone and carriers for the sustained release of steroids | |
| Rathbone et al. | Controlled-release products for the control of the estrus cycle in cattle, sheep, goats, deer, pigs, and horses | |
| US3830907A (en) | Compositions for the sustained release of 17alpha-ethyl-19-nortestosterone | |
| Johnson et al. | Maintenance of pregnancy in ovariectomized cattle with progestin compounds and their effect on progestin levels in the corpus luteum | |
| Blatchford et al. | Responses of the pituitary‐adrenal system of the pig to environmental changes and drugs | |
| IL23565A (en) | Administration of ovulation-controlling medicaments to domestic animals | |
| Britt et al. | Uterine involution, ovarian activity, and fertility after melengestrol acetate and estradiol in early postpartum cows | |
| CA1230557A (en) | Process for treating anestrus in ewes or beef cattle | |
| Shevah et al. | The effect of lactation on the resumption of reproductive activity and the preovulatory release of LH in Finn× Dorset ewes | |
| Greene et al. | Behavioral characteristics of freemartins administered estradiol, estrone, testosterone, and dihydrotestosterone | |
| Oyeyemi et al. | Comparative Responses of West African Dwarf Goats to Three Oestrus Synchronizing Agents. | |
| Dhindsa et al. | Estrous control and calving performance in beef cattle fed 6-methyl-17-acetoxy-progesterone under ranch conditions | |
| MH | Observations on the use of certain orally active progestogens for the control of fertility in women. |